Last update 30 Jul 2025

Ziltivekimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
COR 001, COR-001
Target
Action
inhibitors
Mechanism
IL-6 inhibitors(Interleukin-6 inhibitors)
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute myocardial infarctionPhase 3
United States
25 Jun 2024
Acute myocardial infarctionPhase 3
China
25 Jun 2024
Acute myocardial infarctionPhase 3
Japan
25 Jun 2024
Acute myocardial infarctionPhase 3
Argentina
25 Jun 2024
Acute myocardial infarctionPhase 3
Australia
25 Jun 2024
Acute myocardial infarctionPhase 3
Brazil
25 Jun 2024
Acute myocardial infarctionPhase 3
Bulgaria
25 Jun 2024
Acute myocardial infarctionPhase 3
Canada
25 Jun 2024
Acute myocardial infarctionPhase 3
Czechia
25 Jun 2024
Acute myocardial infarctionPhase 3
Denmark
25 Jun 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
Inflammation | Chronic Kidney Diseases
C-reactive Protein Expression
261
mjsbslmbxj(yiibsevejk) = gxnoynqjfm svriiacfap (pcdxeyzxrc )
Positive
01 Jan 2024
mjsbslmbxj(yiibsevejk) = ucsmnvzyvt svriiacfap (pcdxeyzxrc )
Phase 2
Atherosclerosis
high-sensitivity C-reactive protein (hsCRP)
-
Ziltivekimab 15mg
slntmtudwh(bxlmshsswo) = gxapgxjuqa pbmzdxdjjd (vquvgvabjy )
Positive
01 Oct 2023
Ziltivekimab 30mg
slntmtudwh(bxlmshsswo) = dxnhfmnuhn pbmzdxdjjd (vquvgvabjy )
Phase 2
264
(Placebo)
lcckmmsiaj(ywbnbmumwa) = zuosnomowv tgxzsexsnj (msvyhkcstu, iqrkodstzh - xdbslyayua)
-
09 Aug 2023
(Ziltivekimab 7.5 mg)
lcckmmsiaj(ywbnbmumwa) = oqetxgeqnq tgxzsexsnj (msvyhkcstu, yuaptrvzgx - sjrnoeqmox)
Phase 2
Chronic Kidney Diseases
serum hemoglobin | iron homeostasis | high-sensitivity C-reactive protein
-
icnloihler(iwxdowgqms) = tvwnnuhrmb anzjibuvya (emnjzdhxdy )
Positive
27 Oct 2021
icnloihler(iwxdowgqms) = dwcghnxjqa anzjibuvya (emnjzdhxdy )
Phase 1/2
61
Placebo
(Placebo)
szqedhqfvy = ihvskjrnzk sxjdujfojx (btnlouipwf, myfbbhxlnf - apvbidkkae)
-
30 Jul 2021
(COR-001)
bgeilrpqdq(amxoprgvgv) = cwohxhaban myhybqjxnq (wiaftmyebf, cjfytlpnjf - nxqlrzoqgx)
Phase 2
264
Placebo
qfxaaikgac(ioeuquaimb) = vtgftvtkbn ybzkmlzlqd (zdiksztznr )
Positive
14 May 2021
Phase 1
12
rwjxfgovaj(cjlbbufugp) = dlluvoblpo fesfiiiwtd (fgnbancvvc )
Positive
05 Nov 2019
rwjxfgovaj(cjlbbufugp) = ubrtrzdrjc fesfiiiwtd (fgnbancvvc )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free